MedPath

Effectiveness of homoeopathic medicines in cases of nasal polyp

Phase 3
Conditions
Health Condition 1: J339- Nasal polyp, unspecified
Registration Number
CTRI/2024/05/066813
Lead Sponsor
Dr M P K Homoeopathic Medical College Hospital And Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The patients aged 18 to 75 years

Patients giving volunatary consent for the study.

Case of nasal polyp diagnosed on basis of clinical examination

Cases of nasal polyp ICD-10( CODE-J33.9) criteria

Exclusion Criteria

Cases without proper follow–up will be excluded from the study.

Patients suffering from autoimmune diseases, HIV, etc.

Patient pursuing other treatment and are not willing to leave it.

Complications of nasal polyp.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
According to the score obtained (pre and post <br/ ><br>treatment and post post treatment) from the Sino <br/ ><br>Nasal Outcome test 22 scaleTimepoint: Pre score will be taken at baseline of treatment <br/ ><br>and post score will assessed at the end of study <br/ ><br>that is 12 weeks using the Sino Nasal Outcome <br/ ><br>test 22 scale
Secondary Outcome Measures
NameTimeMethod
Process of individualization plays dominant role in the cases of Nasal polyps. <br/ ><br>Timepoint: 12 months;This study will help to compare the two methods of Totality of symptoms vis-à-vis Preidentified Organopathic medicines in selection of medicine in cases of Nasal polyps.Timepoint: 12 months
© Copyright 2025. All Rights Reserved by MedPath